Education
About Us
Working with TipRanks
Follow Us
Croda International PLC (DE:6CMB)
FRANKFURT:6CMB
6CMB Stock Chart & Stats
€31.87
€0.38(0.96%)
At close: 4:00 PM EST
€31.87
€0.38(0.96%)
Day’s Range― - ―
52-Week Range€27.83 - €37.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€4.24B
Enterprise Value€4.25B
Total Cash (Recent Filing)€172.80M
Total Debt (Recent Filing)€760.30M
Price to Earnings (P/E)60.7
Beta0.87
Next Earnings
Jul 29, 2026EPS Estimate
0.88Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.86
Shares Outstanding139,635,440
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.99
Price to Book (P/B)1.72
Price to Sales (P/S)2.21
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€37.96Price Target Upside19.12% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.02
Revenue Forecast (FY)€20.21M
Bulls Say, Bears Say
Bulls Say
Patented Ingredients & NPSGrowth in patented ingredients and a sizable NPS gain reflect durable product differentiation and stronger customer relationships. Patents and formulation expertise raise switching costs, support premium pricing and recurring B2B demand, helping sustain margins and long‑term revenue resilience.
High‑value End‑market Mix & Geographic DiversificationA structural shift toward consumer, pharma and agriculture and greater non‑Western exposure reduces cyclicality and taps faster growth niches (F&F, plant stem cells, biologics). This portfolio repositioning supports steadier demand, higher addressable markets and improved long‑term growth prospects.
Strong Cash Generation & Conservative LeverageConsistent operating cash flow, positive FCF and reduced net debt provide durable financial flexibility. Conservative leverage and improved cash conversion support funding of transformation, disciplined capex and dividends while insulating the business from cyclical shocks and enabling strategic investments.
Bears Say
Large Exceptional Charges & ImpairmentsMaterial impairments and exceptional charges weaken reported earnings and reveal past overcapacity or misallocated investment. The prospect of further write‑downs and restructuring costs can erode capital, hinder ROIC improvement and prolong the path to sustainable margin recovery.
Pharma Segment Volatility & Policy ExposurePharma Solutions' sensitivity to regulatory and policy shifts reduces predictability of a high‑potential segment. Policy‑driven demand swings make it hard to rely on pharma for steady growth and complicate long‑term planning and investment in scale‑up for breakout opportunities.
Industrial Weakness & Customer ConcentrationA sharp drop in Industrial Specialties and meaningful exposure to one large customer create concentration and cyclical risk. Recovery depends on restoring volumes or diversifying clients; persistent weakness here could dampen group revenue stability and margin progress.
Croda International News
6CMB FAQ
What was Croda International PLC’s price range in the past 12 months?
Croda International PLC lowest stock price was €27.83 and its highest was €37.40 in the past 12 months.
What is Croda International PLC’s market cap?
Croda International PLC’s market cap is €4.24B.
When is Croda International PLC’s upcoming earnings report date?
Croda International PLC’s upcoming earnings report date is Jul 29, 2026 which is in 134 days.
How were Croda International PLC’s earnings last quarter?
Croda International PLC released its earnings results on Feb 24, 2026. The company reported €0.857 earnings per share for the quarter, beating the consensus estimate of €0.792 by €0.065.
Is Croda International PLC overvalued?
According to Wall Street analysts Croda International PLC’s price is currently Undervalued.
Does Croda International PLC pay dividends?
Croda International PLC does not currently pay dividends.
What is Croda International PLC’s EPS estimate?
Croda International PLC’s EPS estimate is 0.88.
How many shares outstanding does Croda International PLC have?
Croda International PLC has 139,635,440 shares outstanding.
What happened to Croda International PLC’s price movement after its last earnings report?
Croda International PLC reported an EPS of €0.857 in its last earnings report, beating expectations of €0.792. Following the earnings report the stock price went up 5.9%.
Which hedge fund is a major shareholder of Croda International PLC?
Currently, no hedge funds are holding shares in DE:6CMB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Croda International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€37.96 (19.12% Upside)
€37.96 (19.12% Upside)
Blogger Sentiment
Bullish
DE:6CMB Sentiment 100%
Sector Average 64%
Sector Average 64%
Insider Transactions
Bought Shares
Worth £20.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.76%
12-Months-Change
Fundamentals
Return on Equity
6.17%
Trailing 12-Months
Asset Growth
-3.21%
Trailing 12-Months
Company Description
Croda International PLC
Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. It operates through four segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The company offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries. It also provides specialty ingredients for self-tanning, color cosmetics, bath and shower, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene, as well as skin, hair, sun, body, and baby care applications; construction chemicals and bitumen additives; dietary supplements; and materials and polymer additives for electronics and devices. In addition, the company offers chemistries, emulsifiers, fuel and power generation additives, and polymer additives; food additives; specialty polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; and packaging, print, and paper chemicals. Further, it provides paints and coatings; active pharmaceutical ingredients; thermal management products; plastic and rubber products; skin health products; hygiene and industrial nonwovens, botanical extracts, tissues, and textile auxiliaries; and water treatment chemicals. Additionally, the company offers bio-based phase change materials for buildings and ventilation, clothing and healthcare, electronics and devices, food and refrigeration, energy storage and recovery, temperature controlled packaging, and vehicles and automotive applications. The company was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
6CMB Stock 12 Month Forecast
Average Price Target
€37.96
▲(19.12% Upside)
Technical Analysis
Options Prices
Currently, No data available
---